MOMA Therapeutics rakes in $150m Series B
MOMA Therapeutics, a biopharmaceutical company, has closed $150 million in Series B financing.
MOMA Therapeutics, a biopharmaceutical company, has closed $150 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination